These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
606 related articles for article (PubMed ID: 32191343)
1. Detection of aberrant methylation of HOXA9 and HIC1 through multiplex MethyLight assay in serum DNA for the early detection of epithelial ovarian cancer. Singh A; Gupta S; Badarukhiya JA; Sachan M Int J Cancer; 2020 Sep; 147(6):1740-1752. PubMed ID: 32191343 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of the Diagnostic Potential of Candidate Hypermethylated Genes in Epithelial Ovarian Cancer in North Indian Population. Singh A; Gupta S; Sachan M Front Mol Biosci; 2021; 8():719056. PubMed ID: 34778370 [TBL] [Abstract][Full Text] [Related]
3. Circulating HOXA9-methylated tumour DNA: A novel biomarker of response to poly (ADP-ribose) polymerase inhibition in BRCA-mutated epithelial ovarian cancer. Rusan M; Andersen RF; Jakobsen A; Steffensen KD Eur J Cancer; 2020 Jan; 125():121-129. PubMed ID: 31865042 [TBL] [Abstract][Full Text] [Related]
4. Leveraging locus-specific epigenetic heterogeneity to improve the performance of blood-based DNA methylation biomarkers. Miller BF; Pisanic Ii TR; Margolin G; Petrykowska HM; Athamanolap P; Goncearenco A; Osei-Tutu A; Annunziata CM; Wang TH; Elnitski L Clin Epigenetics; 2020 Oct; 12(1):154. PubMed ID: 33081832 [TBL] [Abstract][Full Text] [Related]
5. Aberrantly Methylated cfDNA in Body Fluids as a Promising Diagnostic Tool for Early Detection of Breast Cancer. Stastny I; Zubor P; Kajo K; Kubatka P; Golubnitschaja O; Dankova Z Clin Breast Cancer; 2020 Dec; 20(6):e711-e722. PubMed ID: 32792225 [TBL] [Abstract][Full Text] [Related]
6. Aberrant Promoter Hypermethylation of RASSF1a and BRCA1 in Circulating Cell-Free Tumor DNA Serves as a Biomarker of Ovarian Carcinoma. S SK; Swamy SN; Premalatha CS; Pallavi VR; Gawari R Asian Pac J Cancer Prev; 2019 Oct; 20(10):3001-3005. PubMed ID: 31653147 [TBL] [Abstract][Full Text] [Related]
7. Transformer-based AI technology improves early ovarian cancer diagnosis using cfDNA methylation markers. Li G; Zhang Y; Li K; Liu X; Lu Y; Zhang Z; Liu Z; Wu Y; Liu F; Huang H; Yu M; Yang Z; Zheng X; Guo C; Gao Y; Wang T; Fok M; Yiu-Nam Lau J; Shi K; Gu X; Guo L; Luo H; Zeng F; Zhang K Cell Rep Med; 2024 Aug; 5(8):101666. PubMed ID: 39094578 [TBL] [Abstract][Full Text] [Related]
8. Diagnostic Power of DNA Methylation Classifiers for Early Detection of Cancer. Roy D; Tiirikainen M Trends Cancer; 2020 Feb; 6(2):78-81. PubMed ID: 32061307 [TBL] [Abstract][Full Text] [Related]
9. The potential of circulating tumor DNA methylation analysis for the early detection and management of ovarian cancer. Widschwendter M; Zikan M; Wahl B; Lempiäinen H; Paprotka T; Evans I; Jones A; Ghazali S; Reisel D; Eichner J; Rujan T; Yang Z; Teschendorff AE; Ryan A; Cibula D; Menon U; Wittenberger T Genome Med; 2017 Dec; 9(1):116. PubMed ID: 29268796 [TBL] [Abstract][Full Text] [Related]
10. Cell-free DNA is abundant in ascites and represents a liquid biopsy of ovarian cancer. Werner B; Yuwono N; Duggan J; Liu D; David C; Srirangan S; Provan P; ; DeFazio A; Arora V; Farrell R; Lee YC; Warton K; Ford C Gynecol Oncol; 2021 Sep; 162(3):720-727. PubMed ID: 34454680 [TBL] [Abstract][Full Text] [Related]
11. Development of a multiplex MethyLight assay for the detection of DAPK1 and SOX1 methylation in epithelial ovarian cancer in a north Indian population. Kaur M; Singh A; Singh K; Gupta S; Sachan M Genes Genet Syst; 2016 Nov; 91(3):175-181. PubMed ID: 27452040 [TBL] [Abstract][Full Text] [Related]
12. A new approach to epigenome-wide discovery of non-invasive methylation biomarkers for colorectal cancer screening in circulating cell-free DNA using pooled samples. Gallardo-Gómez M; Moran S; Páez de la Cadena M; Martínez-Zorzano VS; Rodríguez-Berrocal FJ; Rodríguez-Girondo M; Esteller M; Cubiella J; Bujanda L; Castells A; Balaguer F; Jover R; De Chiara L Clin Epigenetics; 2018; 10():53. PubMed ID: 29686738 [TBL] [Abstract][Full Text] [Related]
13. Cumulative methylation alternations of gene promoters and protein markers for diagnosis of epithelial ovarian cancer. Xing BL; Li T; Tang ZH; Jiao L; Ge SM; Qiang X; OuYang J Genet Mol Res; 2015 May; 14(2):4532-40. PubMed ID: 25966226 [TBL] [Abstract][Full Text] [Related]
14. Liquid biopsy in ovarian cancer using circulating tumor DNA and cells: Ready for prime time? Asante DB; Calapre L; Ziman M; Meniawy TM; Gray ES Cancer Lett; 2020 Jan; 468():59-71. PubMed ID: 31610267 [TBL] [Abstract][Full Text] [Related]
15. Application of multiplex nested methylated specific PCR in early diagnosis of epithelial ovarian cancer. Wang B; Yu L; Yang GZ; Luo X; Huang L Asian Pac J Cancer Prev; 2015; 16(7):3003-7. PubMed ID: 25854397 [TBL] [Abstract][Full Text] [Related]
16. Circulating cell-free DNA-based epigenetic assay can detect early breast cancer. Uehiro N; Sato F; Pu F; Tanaka S; Kawashima M; Kawaguchi K; Sugimoto M; Saji S; Toi M Breast Cancer Res; 2016 Dec; 18(1):129. PubMed ID: 27993161 [TBL] [Abstract][Full Text] [Related]
17. A Panel of Novel Detection and Prognostic Methylated DNA Markers in Primary Non-Small Cell Lung Cancer and Serum DNA. Ooki A; Maleki Z; Tsay JJ; Goparaju C; Brait M; Turaga N; Nam HS; Rom WN; Pass HI; Sidransky D; Guerrero-Preston R; Hoque MO Clin Cancer Res; 2017 Nov; 23(22):7141-7152. PubMed ID: 28855354 [No Abstract] [Full Text] [Related]
18. Epigenetic analysis of sporadic and Lynch-associated ovarian cancers reveals histology-specific patterns of DNA methylation. Niskakoski A; Kaur S; Staff S; Renkonen-Sinisalo L; Lassus H; Järvinen HJ; Mecklin JP; Bützow R; Peltomäki P Epigenetics; 2014 Dec; 9(12):1577-87. PubMed ID: 25625843 [TBL] [Abstract][Full Text] [Related]
19. Association between HIC1 and RASSF1A promoter hypermethylation with MTHFD1 G1958A polymorphism and clinicopathological features of breast cancer in Iranian patients. Rasti M; Tavasoli P; Monabati A; Entezam M Iran Biomed J; 2009 Oct; 13(4):199-206. PubMed ID: 19946345 [TBL] [Abstract][Full Text] [Related]
20. Assessing ZNF154 methylation in patient plasma as a multicancer marker in liquid biopsies from colon, liver, ovarian and pancreatic cancer patients. Miller BF; Petrykowska HM; Elnitski L Sci Rep; 2021 Jan; 11(1):221. PubMed ID: 33420235 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]